Wordt geladen...
A phase I study of intravenous bryostatin 1 in patients with advanced cancer.
Bryostatin 1 is a novel antitumour agent derived from Bugula neritina of the marine phylum Ectoprocta. Nineteen patients with advanced solid tumours were entered into a phase I study to evaluate the toxicity and biological effects of bryostatin 1. Bryostatin 1 was given as a one hour intravenous inf...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Publishing Group
1993
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1968558/ https://ncbi.nlm.nih.gov/pubmed/8347500 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|